Yeh, I was a supporter up until this CR, but I can't see an outcome from here on that is positive for shareholders. Either way, I don't have more money to put into this highly highly speculative stock
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%